Your browser doesn't support javascript.
loading
The mesenchymal stromal cell secretome promotes tissue regeneration and increases macrophage infiltration in acute and methicillin-resistant Staphylococcus aureus-infected skin wounds in vivo.
Rajesh, Aarthi; Ju, Esther Da Eun; Oxford, Kelly A; Harman, Rebecca M; Van de Walle, Gerlinde R.
Afiliación
  • Rajesh A; Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Ju EDE; Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Oxford KA; Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Harman RM; Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Van de Walle GR; Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Electronic address: grv23@cornell.edu.
Cytotherapy ; 26(11): 1400-1410, 2024 Nov.
Article en En | MEDLINE | ID: mdl-38944795
ABSTRACT
BACKGROUND

AIMS:

The prevalence of chronic wounds continues to be a burden in human medicine. Methicillin-resistant Staphylococcus aureus (MRSA) is commonly isolated from infected wounds. MRSA infections primarily delay healing by impairing local immune cell functions. This study aimed to investigate the potential of mesenchymal stromal cell (MSC)-secreted bioactive factors, defined as the secretome, to improve innate immune responses in vivo. MSCs were isolated from the bone marrow of horses, which serve as valuable translational models for wound healing. The MSC secretome, collected as conditioned medium (CM), was evaluated in vivo using mouse models of acute and MRSA-infected skin wounds.

METHODS:

Punch biopsies were used to create two full-thickness skin wounds on the back of each mouse. Acute wounds were treated daily with control medium or bone marrow-derived MSC (BM-MSC) CM. The antibiotic mupirocin was administered as a positive control for the MRSA-infected wound experiments. Wounds were photographed daily, and wound images were measured to determine the rate of closure. Trichrome staining was carried out to examine wound tissue histologically, and immunofluorescence antibody binding was used to assess immune cell infiltration. Wounds in the MRSA-infected model were swabbed for quantification of bacterial load.

RESULTS:

Acute wounds treated with BM-MSC CM showed accelerated wound closure compared with controls, as illustrated by enhanced granulation tissue formation and resolution, increased vasculature and regeneration of hair follicles. This treatment also led to increased neutrophil and macrophage infiltration. Chronic MRSA-infected wounds treated with BM-MSC CM showed reduced bacterial load accompanied by better resolution of granulation tissue formation and increased infiltration of pro-healing M2 macrophages compared with control-treated infected wounds.

CONCLUSIONS:

Collectively, our findings indicate that BM-MSC CM exerts pro-healing, immunomodulatory and anti-bacterial effects on wound healing in vivo, validating further exploration of the MSC secretome as a novel treatment option to improve healing of both acute and chronic wounds, especially those infected with antibiotic-resistant bacteria.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piel / Infecciones Estafilocócicas / Cicatrización de Heridas / Staphylococcus aureus Resistente a Meticilina / Células Madre Mesenquimatosas / Secretoma / Macrófagos Límite: Animals / Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piel / Infecciones Estafilocócicas / Cicatrización de Heridas / Staphylococcus aureus Resistente a Meticilina / Células Madre Mesenquimatosas / Secretoma / Macrófagos Límite: Animals / Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido